CCT241533

ATP-competitive inhibitor of CHEK2

Structure

Information

  • CHEK2
  • ATP-competitive inhibitor

In Vitro Validations

Uniprot ID: O96017
Target Class: Protein kinase
Target SubClass: CAMK
Potency: Ki
Potency Value: 1.16 nM
Potency Assay: Radiometric assay; IC50 in kinase assay = 3 nM
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Serine/threonine-protein kinase Chk2, RAD53, CHK2, ...

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Potency end-point : IC50 CHEK1 245 nM
Potency assay (off target): In a radiometric binding assay, 1 uM CCT241533 inhibited >80% of AHK, MARK3, GCK and MLK1 activity.
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating

SERP Comments:

CCT241533 is a potent (biochemical IC50 3 nM) and selective (63-fold vs CHK1, >90% inhibition of 3 out of 85 kinases tested at 1 uM) inhibitor of CHK2. Mechanistic inhibition of CHK2 in cancer cells (HT29) has been demonstrated at concentrations from 1 uM (J Med Chem 2011, 54(2), 580-590) and further cell activity is described (Cancer Res 2011, 71(2), 463-472) at similar concentrations.

(last updated: 19 Jun 2016 )

SERP Ratings

In Cell Rating

SERP Comments:

This probe has a very good selectivity profile; activity was found for only four kinases (PHK, GCK, MLKI, and MARK3) out of a panel of 85. The X-ray structure shows CCT241533 bound to CHK2 in the kinase domain region at a resolution of 2.3 Angstrom. Selectivity of CCT241533 for CHK2 over CHK1 is 80-fold. Pairing with PARP inhibitors enhances cellular toxicity. No PK data are available; solubility has been indicated in DMSO only. This probe is commercially available up to 100 mg of material, and scaled-up synthesis is possible.

(last updated: 19 Jun 2016 )

SERP Ratings

In Cell Rating
In Model Organisms

SERP Comments:

CCT241533 is a selective, ATP-competitive CHEK2 inhibitor with biochemical (3 nM) and cellular activity. The compound also inhibits CHEK1 in vitro at 190-245 nM and potentiated the anti-proliferative effect of a PARP inhibitor in p53-minus cancer cells. The compound blocks CHEK2 autophosphorylation in response to DNA damage from bleomycin, etoposide, ionizing radiation in p53-null HT29 and HeLa cells, but not in p53 wild-type A549 cells. CCT241533 did not potentiate the cytotoxicity of bleomycin, however. The compound also blocked CHEK2 activity in three human tumor cell lines HT29 (GI50=1.7 uM), HeLa (GI50=2.2 uM) and MCF7 (GI50=5.1 uM) and protected mouse thymocytes from apoptosis by ionizing radiation. 

(last updated: 22 May 2017 )